Form 4: Saba Capital Management Increases Stake in BlackRock Health Sciences Term Trust (BMEZ)

Saba Capital Management, L.P. reports increased ownership in BlackRock Health Sciences Term Trust (BMEZ) through recent stock purchases.

Summary

• Saba Capital Management, L.P. has increased its holdings in BlackRock Health Sciences Term Trust (BMEZ).
• On September 17, 2024, Saba Capital acquired 27,148 shares at a price of $15.93 per share.
• Following this transaction, Saba Capital's indirect ownership totaled 20,565,579 shares.
• On September 18, 2024, Saba Capital acquired an additional 20,534 shares at $15.88 per share.
• This brought their total indirect ownership to 20,586,113 shares.
• Boaz Weinstein is also listed as a reporting person with a director and 10% owner relationship to the issuer.

Sentiment

Score: 6

Explanation: Neutral sentiment. The document simply reports transactions. The increased stake could be seen as a positive, but without further context, it's difficult to assess the overall impact.

Positives

• Saba Capital Management's increased investment could be interpreted as a positive signal for BlackRock Health Sciences Term Trust (BMEZ).

Industry Context

Hedge funds like Saba Capital often take significant positions in closed-end funds like BMEZ to potentially influence fund strategy or capitalize on perceived undervaluation.

Stakeholder Impact

• Shareholders of BMEZ may react to the increased ownership by Saba Capital Management.

Key Dates